Evaluation of Non-dietary Alternatives for Treatment of Adults With Celiac Disease.
作者信息
Freeman Hugh James
机构信息
Department of Medicine (Gastroenterology), University of British Columbia, Vancouver, BC, Canada.
出版信息
Front Nutr. 2020 Oct 19;7:562503. doi: 10.3389/fnut.2020.562503. eCollection 2020.
Abstract
摘要
相似文献
1
Evaluation of Non-dietary Alternatives for Treatment of Adults With Celiac Disease.
Front Nutr. 2020 Oct 19;7:562503. doi: 10.3389/fnut.2020.562503. eCollection 2020.
2
Defining gluten refractory enteropathy.
Eur J Gastroenterol Hepatol. 2001 May;13(5):561-5. doi: 10.1097/00042737-200105000-00016.
3
Refractory celiac disease.
Gastroenterology. 2000 Jul;119(1):243-51. doi: 10.1053/gast.2000.8530.
4
Celiac sprue.
Semin Gastrointest Dis. 2002 Oct;13(4):232-44.
5
Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study.
Gastroenterology. 2009 Mar;136(3):816-23. doi: 10.1053/j.gastro.2008.11.040. Epub 2008 Nov 24.
6
Emerging drugs for coeliac disease.
Expert Opin Emerg Drugs. 2014 Dec;19(4):533-44. doi: 10.1517/14728214.2014.959490. Epub 2014 Sep 15.
7
Identifying and improving adherence to the gluten-free diet in people with coeliac disease.
Proc Nutr Soc. 2019 Aug;78(3):418-425. doi: 10.1017/S002966511800277X. Epub 2019 Jan 11.
8
Intakes of nutrients in Italian children with celiac disease and the role of commercially available gluten-free products.
J Hum Nutr Diet. 2013 Oct;26(5):436-44. doi: 10.1111/jhn.12026. Epub 2012 Dec 17.
9
The broad spectrum of celiac disease and gluten sensitive enteropathy.
Clujul Med. 2016;89(3):335-42. doi: 10.15386/cjmed-698. Epub 2016 Jul 28.
10
Dietary and symptom assessment in adults with self-reported non-coeliac gluten sensitivity.
Clin Nutr ESPEN. 2019 Jun;31:88-94. doi: 10.1016/j.clnesp.2019.02.012. Epub 2019 Mar 11.
本文引用的文献
1
Placebo and Nocebo Effects.
N Engl J Med. 2020 Feb 6;382(6):554-561. doi: 10.1056/NEJMra1907805.
2
Evolving Therapy for Celiac Disease.
Front Pediatr. 2019 May 14;7:193. doi: 10.3389/fped.2019.00193. eCollection 2019.
3
Novel Nondietary Therapies for Celiac Disease.
Cell Mol Gastroenterol Hepatol. 2019;8(3):335-345. doi: 10.1016/j.jcmgh.2019.04.017. Epub 2019 May 27.
4
Role of biopsy in diagnosis and treatment of adult celiac disease.
Gastroenterol Hepatol Bed Bench. 2018 Summer;11(3):191-196.
5
Perspective: Gluten-Free Products for Patients with Celiac Disease Should Not Contain Trace Levels.
Adv Nutr. 2017 May 15;8(3):409-411. doi: 10.3945/an.116.014472. Print 2017 May.
6
Dietary compliance in celiac disease.
World J Gastroenterol. 2017 Apr 21;23(15):2635-2639. doi: 10.3748/wjg.v23.i15.2635.
7
Tax-deductible provisions for gluten-free diet in Canada compared with systems for gluten-free diet coverage available in various countries.
Can J Gastroenterol Hepatol. 2015 Mar;29(2):104-10. doi: 10.1155/2015/508156.
8
Non-dietary forms of treatment for adult celiac disease.
World J Gastrointest Pharmacol Ther. 2013 Nov 6;4(4):108-12. doi: 10.4292/wjgpt.v4.i4.108.
9
Optimising delivery of care in coeliac disease - comparison of the benefits of repeat biopsy and serological follow-up.
Aliment Pharmacol Ther. 2013 Nov;38(10):1278-91. doi: 10.1111/apt.12510. Epub 2013 Oct 5.
10
Refractory celiac disease and sprue-like intestinal disease.
World J Gastroenterol. 2008 Feb 14;14(6):828-30. doi: 10.3748/wjg.14.828.
Zotero 插件